Literature DB >> 30729371

Exploring metabolic and inflammatory abnormalities in rheumatoid arthritis patients developing stroke disease: a case-control study using electronic medical record data in northern China.

Fangran Xin1, Lingyu Fu2,3, Haina Liu4, Yunwei Xu5, Tingting Wei1, Meng Chen1.   

Abstract

OBJECTIVES: Intend to investigate the roles of serum lipids, inflammatory markers, and serological status in rheumatoid arthritis and stroke patients by using case-control study.
MATERIALS AND METHODS: Clinical data were retrieved from the electronic medical record of the First Affiliated Hospital of China Medical University during January 2011 to March 2018. The obtained data were categorized into case groups and three control groups, in the ratios of 1:2, respectively, with all matching age and gender. Multinomial logistic regression analysis and restricted cubic spline were conducted examining the associations between serum lipids, inflammatory markers, serological status, and the risk of stroke among RA patients.
RESULTS: The present studies included 1057 study subjects. The elevated ESR, LDL-C levels, and much higher CRP levels ≥ 230 mg/L were independent risk factors for RA patients in developing stroke. Furthermore, we found that ESR and LDL-C levels could exhibit a linear association with the risk of comorbid stroke while CRP level had a nonlinearity association with stroke risk among RA patients.
CONCLUSIONS: A close monitoring is required for RA patients with dyslipidemia and elevated inflammatory markers, and the primary stroke preventive strategies should be directed against these risk factors.

Entities:  

Keywords:  Dyslipidemia; Inflammatory marker; Rheumatoid arthritis; Serum lipids; Stroke

Mesh:

Substances:

Year:  2019        PMID: 30729371     DOI: 10.1007/s10067-019-04440-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  33 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  C-reactive protein and the future risk of thromboembolic stroke in healthy men.

Authors:  J David Curb; Robert D Abbott; Beatriz L Rodriguez; Pamela Sakkinen; Jordan S Popper; Katsuhiko Yano; Russell P Tracy
Journal:  Circulation       Date:  2003-04-07       Impact factor: 29.690

3.  Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study.

Authors:  Hyon K Choi; Miguel A Hernán; John D Seeger; James M Robins; Frederick Wolfe
Journal:  Lancet       Date:  2002-04-06       Impact factor: 79.321

Review 4.  Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.

Authors:  Srdjan Prodanovich; Srdjan Prodanowich; Fangchao Ma; J Richard Taylor; Candido Pezon; Tahira Fasihi; Robert S Kirsner
Journal:  J Am Acad Dermatol       Date:  2005-02       Impact factor: 11.527

5.  Cardiovascular death in rheumatoid arthritis: a population-based study.

Authors:  Hilal Maradit-Kremers; Paulo J Nicola; Cynthia S Crowson; Karla V Ballman; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2005-03

6.  Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects.

Authors:  Inmaculada Del Rincón; Ken Williams; Michael P Stern; Gregory L Freeman; Daniel H O'Leary; Agustín Escalante
Journal:  Arthritis Rheum       Date:  2003-07

7.  Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.

Authors:  Bernard Combe; Alain Cantagrel; Philippe Goupille; Marie-Cecile Bozonnat; Jean Sibilia; Jean-F Eliaou; Olivier Meyer; Jacques Sany; Anne Dubois; Jean-Pierre Daurès; Maxime Dougados
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

8.  Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients.

Authors:  Francis Guillemin; Nathalie Gérard; Miek van Leeuwen; Liv Marit Smedstad; Tore Kristian Kvien; Wim van den Heuvel
Journal:  J Rheumatol       Date:  2003-12       Impact factor: 4.666

9.  Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.

Authors:  Frederick Wolfe; Bruce Freundlich; Walter L Straus
Journal:  J Rheumatol       Date:  2003-01       Impact factor: 4.666

10.  Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.

Authors:  Dursun Dursunoğlu; Harun Evrengül; Bülent Polat; Halil Tanriverdi; Veli Cobankara; Asuman Kaftan; Mustafa Kiliç
Journal:  Rheumatol Int       Date:  2004-07-31       Impact factor: 2.631

View more
  2 in total

1.  Development and validation of a nomogram for predicting stroke risk in rheumatoid arthritis patients.

Authors:  Fangran Xin; Lingyu Fu; Bowen Yang; Haina Liu; Tingting Wei; Cunlu Zou; Bingqing Bai
Journal:  Aging (Albany NY)       Date:  2021-06-03       Impact factor: 5.682

Review 2.  Potential Role of Atrial Myopathy in the Pathogenesis of Stroke in Rheumatoid Arthritis and Psoriasis: A Conceptual Framework and Implications for Prophylaxis.

Authors:  Milton Packer
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.